Federal contract award
75A50124F61009
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 75A50122D00004 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $396.0K |
| Current contract value | $396.0K |
| Potential contract value / ceiling | $396.0K |
| Start date | Feb 22, 2024 |
| Current end date | May 21, 2027 |
| Potential end date | May 21, 2027 |
| Latest award activity | May 1, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 1, 2026 | P00007 | $126.2K | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| Feb 2, 2026 | P00006 | $0 | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| Jan 22, 2026 | P00005 | $0 | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| Jun 11, 2025 | P00004 | $0 | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| Feb 18, 2025 | P00003 | $152.2K | (1) PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO AN HHS DESIGNATED PUBLIC HEALTH EMERGENCY; (2) PRODUCE VACCINES AGAINST INFLUENZA VIRUS, AND INFLUENZA V |
| Nov 5, 2024 | P00002 | $0 | THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO MAKE ADMINISTRATIVE CORRECTIONS TO THE CLIN NUMBERING AND THE START YEAR FOR OPTION PERIOD 4 IN SECTION B.2 AND THE ENDING DATE FOR OPTION 1 IN SECTION F.1 PERIOD OF PERFORMANCE. IN ADDITION, CHANGE TH |
| Apr 22, 2024 | P00001 | $88.2K | -2/21/2025. 2. REVISE THE POP OF OPTION PERIOD 1 FROM 5/22/2024 - 5/21/2025 (12-MONTHS) TO 5/22/2024 - 2/21/2025 (9-MONTHS). OPTION PERIOD 1 DECREASED BY $30,270.00 FROM $118,425.00 TO $88,155.00. 3. ADD OPTION PERIOD 4 WITH A POP FROM 2/22/20 |
| Feb 21, 2024 | 0 | $29.4K | THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE MEDICAL COUNTERMEASURES (MCMS), SUCH AS VACCINES AND ADJUVANTS, FOR PANDEMIC PREPAREDNESS AND RESPONSE OR AS REQUIRED IN RESPONSE TO A HHS DESIGNATED |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-05-21 (208 days from calculation)
- +35 points
- 29 historical awards in this buyer and category group
- +15 points
- 8 recorded award transactions
- +10 points
- Latest award action: 2026-05-01
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.